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S U M M A R Y
Histoplasmosis is a deep mycosis caused by Histoplasma capsulatum, which is endemic in many areas of
theworld but is relatively rare in China. Although themajority of cases present as amild tomoderate ﬂu-
like disease requiring only supportive therapy, approximately 1% of patients experience more serious
pulmonary and extrapulmonary disease, which can be life-threatening if diagnosis is delayed or the
treatment is not initiated rapidly. Deﬁnitive diagnosis is usually made by a combination of culture,
detection of the organism in tissues, measurement of antibodies, and detection of antigen. We present
the case of a 51-year-old patient who presented with histoplasmosis only, with several ulcerated lesions
in the oral cavity and without HIV infection, who did not show any detectable signs and symptoms of
systemic disease or extra-oral manifestations. Histopathological analysis indicated a chronic
inﬂammatory process with granulomas with yeast-like organisms. Isolation of H. capsulatum and
molecular identiﬁcation provided the deﬁnitive diagnosis. Treatment with oral itraconazole led to
remission of the oral lesions. This is the ﬁrst Chinese case report of localized histoplasmosis with lesions
restricted to the mouth in an HIV-negative patient.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Histoplasmosis, also known as Darling’s disease, is a systemic
fungal infection caused by Histoplasma capsulatum, which is a
dimorphic pathogenic fungus that grows in soil and material
contaminated with bat of bird droppings. There are three varieties
of H. capsulatum: capsulatum and duboisii, which are pathogenic to
humans, and farciminosum, which is an equine pathogen. H.
capsulatum is endemic in certain areas of the USA, South America,
Malaysia and Indonesia. Histoplasmosis is clinically classiﬁed into
three forms: (1) a primary acute pulmonary form that is usually
asymptomatic; (2) a chronic pulmonary form that often occurs in
the presence of underlying pulmonary disease; and (3) a
disseminated form, which is characterized by the progressive
spread of infection to extrapulmonary sites.1
Disseminated histoplasmosis mainly affects the mononuclear
phagocyte system, with bone marrow involvement resulting in
changes in the blood picture. It often occurs in immunosuppressed
patients.1 Oral manifestations of histoplasmosis, although usually
associated with the chronic disseminated form of the disease,
constitute a rare event in HIV-negative patients without underly-* Corresponding author. Tel.: +86 2368765917; fax: +86 2368765917.
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tongue, palate, or lips.2 Oral lesions, when present, can manifest in
a variety of forms, such as ulcers and erythematous or vegetative
nodules. Frequently, in cases of disseminated infection, such
lesions appear to be the primary or only manifestation. Neverthe-
less, few cases of apparently initial mucocutaneous histoplasmosis
in patients without detectable systemic involvement have been
reported since 1946.2
We report herein a case of histoplasmosis in an HIV-negative
patientwith lesions exclusively in the oral cavity butwithout other
subjacent underlying disease.
2. Case report
A 51-year-old country veterinarian from the suburb of Chongq-
ing, a city located in southwest China, presented to the Department
of Dermatology of Southwest Hospital with a two-month history of
a painful oral lesion. At that time, the patient was not taking any
medication and had no history of systemic disease; however he had
suffered a weight loss of approximately 3 kg over the course of
about two months. The patient did not report previous blood
transfusions or surgeries. He did not report a history of traveling and
never went out of the local district. Importantly, he related that he
had had direct contact with the excreta of poultry, equines, and pigs
during his clinical work and had taken inadequate precautions. A
general clinical examination demonstrated a patient with normalses. Published by Elsevier Ltd. All rights reserved.
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Figure 1. Clinical aspects of the oral lesions. Lesions due to Histoplasma capsulatum
on the palate of the oral cavity, crater-like ulcers, with inﬂamed base and regular,
elevated, well demarcated, and hard borders.
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without edema. No lymphadenopathy or hepatosplenomegaly
was palpated on physical examination. The abdomen was soft
and non-rigid with normal bowel sounds. Cardiac auscultation
revealed a regular rate and rhythm, and normal breath sounds.
Neurological examination did not reveal any abnormalities.
Examination of the oral cavity revealed two crater-like ulcers,
with inﬂamed base and regular, elevated, well demarcated and
hard borders. The right lesion was 3 cm in diameter at its widest
and was located in the right soft palate, extending to the hard
palate. It was friable and bled upon scraping and was mildly
painful to palpation. Another regular, elliptic, ulcerated lesionwith
the same characteristics was observed in the left soft palate
(Figure 1). Examination of the neck did not reveal lymphadenopa-
thy. X-ray of the paranasal sinuses and chest and abdominal
ultrasonography did not demonstrate alterations. Because the
patient did not respond to the usual treatment for the oral ulcer, we
considered the possibilities of primary chancre, squamous cell
carcinoma, herpes simplex virus infection, and histoplasmosis.
Antibodies to HIV and syphilis were negative. A leukopenia
(2.9  109/l; normal 4–10  109/l) was detected on blood count.
Levels of urea, creatinine, bilirubins, alkaline phosphatase,
glutamic oxaloacetic transaminase, and glutamic pyruvic trans-
aminasewere all normal. Direct sputum examinationwas negative
in three samples for fungus and alcohol–acid-resistant bacillus.
Blood cultures were also negative. Both direct smear examination
and fungal culture of bone marrow were negative.
A biopsy was performed on the large lesion in the palate. The
tissue fragments were sent for histopathological and microbiolog-
ical examination. Histopathology revealed a granulomatous
chronic inﬂammatory process, and a few yeast-like cells were
found when stained by periodic acid-Schiff stain (Figure 2A). After
[(Figure_2)TD$FIG]Figure 2. Experimental diagnosis. (A) Histopathology revealed a granulomatous chroni
periodic acid-Schiff stain (PAS  100). (B) Scanning electron microscope image of the sli
lower plate, yeast phase on blood plane cultured at 37 8C. (D) Gel electrophoresis of IT15 days of culture on potato dextrose agar at 25 8C, white
ﬁlamentous colonies were observed on the slants. Microscopic
examination of slide cultures on potato dextrose agar under
appropriate biosafety conditions, revealed septate hyaline hyphae
and globose macroconidia, the latter clearly shown under the
scanning electron microscope (Figure 2B). Phase conversion of
yeast and hyphae conﬁrmed the H. capsulatum identity when
cultured at different temperatures (Figure 2C).
As histoplasmosis is comparatively rare in China and the
patient, who had no HIV infection, showed no detectable signs andc inﬂammatory process, and a few yeast-like cells were found when stained with
de culture (1000). (C) Upper plate, mould phase on blood plane cultured at 25 8C;
S1, ITS2, D1/D2 PCR product on 1.2% agarose.
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isolate was further evaluated by molecular analyses. DNA was
extracted from a loopful of the yeast phase by proteinase K
digestion, followed by chloroform–phenol extraction and isopro-
panol precipitation. Two segments of the nuclear rRNA gene that
included the internal transcribed spacer 1 (ITS1) region and the D1/
D2 region were ampliﬁed with primers (ITS1, upper primer
50-TCCGTAGGTGAACCTGCGG-30, down primer 50-GCTGCGTTCTT-
CATCGATGC-30; D1/D2 upper primer 50-GCATATCAATAAGCGGAG-
GAAAAG-30, down primer 50-GGTCCGTGTTTCAAGACGG-30), which
were previously designed for ampliﬁcation of pathogenic fungi3,4
(Figure 2D). The resultant products were sequenced from both the
50 and the 30 ends with an automated sequencer (Invitrogen
3730XL DNA sequencer).
A 291-base pair segment was produced by ampliﬁcation with
primers ITS1. The sequence of our strain showed 98.3% (286/291)
identity with Ajellomyces capsulatus var. duboisii and A. capsulatus
isolate H64. By ampliﬁcation with primers D1/D2, a 573-bp
segment was obtained. The sequence of our strain showed 99.5%
(570/573) identity with A. capsulatus isolate UAMH 3536.
The patient was treated with oral itraconazole 200 mg twice
daily. After 60 days, the oral lesion had completely resolved. Six
months after cessation of the antifungal treatment, the patient had
no signs of recurrent oral lesions. There was no evidence of
persistent H. capsulatum infection.
3. Discussion
Histoplasmosis was ﬁrst described in 1906 by an American
pathologist, Samuel Darling.5 It took 30 years to prove that
histoplasmosiswas caused byH. capsulatum.H. capsulatum is a true
dimorphic fungus that exists as amold in the environment and as a
true yeast in tissues at 35–37 8C. There are two varieties of H.
capsulatum that are pathogenic to humans, H. capsulatum var.
capsulatum and H. capsulatum var. duboisii, and a third variety that
is an equine pathogen, H. capsulatum var. farciminosum, which
exists in Africa.6
Histoplasmosis is primarily a pulmonary disease, and the
environmental reservoir is soil. People acquire the infection
through the inhalation of conidial forms present in the
environment, such as in caves with resident bats and soils
inhabited by chickens. The endemic area includes the Ohio and
Mississippi river valleys, Central and South America, and
microfoci in the eastern USA, southern Europe, Africa, and
southeastern Asia. The ﬁrst case of histoplasmosis in China was
reported in 1958, in a traveler returning from the USA. About 100
cases of histoplasmosis have been reported in China in the 50
years since the ﬁrst patient. Most of the diseases are sporadic,
primarily affecting the lungs or disseminating to other organs.
Interestingly, the number of male patients is higher than that of
female ones.
A recent investigation into its epidemiology indicates that the
rate ofH. capsulatum infection is high in China. In the central south
region (Shaoyang city), the positive skin reaction rateswere 22.4%
in the normal population and 31.6% in tuberculosis (TB) patients.
In the east of China (Nanjing city), the rates were 15.1% in the
normal population and 17.7% in TB patients. In the southwest of
China (Chengdu city), these rates were 21.8% and 54.4%,
respectively. The data suggest that the rate of H. capsulatum
infection in the southeast of China is higher than that in the
northwest, and that the infection rate in patients with pulmonary
TB is higher than in normal people and other pneumonopathy
patients.7
Like most other fungal diseases, predisposing factors for
histoplasmosis remain unclear. It is likely that exposure to the
infectious particles leads to a positive skin test inmost individuals.However, such exposure has not been recorded in all individuals
with the disseminated state. There is recent experimental evidence
demonstrating that susceptibility to H. capsulatum strongly
depends on genetic predisposition.8 The outcome of infection
with H. capsulatum is determined by dynamic interactions
between innate immunity, adaptive immunity and fungal viru-
lence factors.9 The microconidia formed in the mold phase of H.
capsulatum are easily aerosolized, inhaled into the lungs, and then
phagocytized by alveolar macrophages. Moreover, control of H.
capsulatum infection is largely based on activation of cellular
immunity in concert with innate responses.10 If cell-mediated
immunity is deﬁcient because of underlying illnesses or immuno-
suppressive drugs, the organisms remain viable within macro-
phages and cause progressive infection.11
In all reported cases, disseminated forms are more associated
with immunodeﬁcient subjects, notably those with HIV infection.
Oral histoplasmosis has frequently been reported in HIV-seroposi-
tive patients.12 To our knowledge, this is the ﬁrst reported case of
oral histoplasmosis in an HIV-negative patient without detectable
systemic involvement described in China.
Patients infected with H. capsulatum show a variety of clinical
manifestations, which cause difﬁculties in diagnosis. The differen-
tial diagnosis of histoplasmosis with other ulcerative oral diseases
is often made by a tissue biopsy or culture of H. capsulatum. No
gender difference has been observed in the incidence of this
disease, although most of the reported cases are male. Oral
histoplasmosis is usually diagnosed after the discovery of lesions in
the upper aero-digestive tracts in the absence of pulmonary signs.
These lesions may remain the only location for a long period of
time,13 and can be misinterpreted as aphthous and/or traumatic
ulcers, ulcerative necrotic gingivitis or stomatitis, other mycoses,
squamous cell carcinoma, and lymphomas2,14 The oral lesions are
initially budding or wart-like and then develop into ulcerating,
indurated and painful lesions.14 We considered the case presented
in this paper to have a primary localized infection of H. capsulatum
as no systemic signs or symptoms could be detected and treated as
such.15 In fact, the patient was cured with oral antifungal agents
and there was no recurrence after six months of follow-up.
Although our patient lives in a nonendemic area, he reported
frequent contact with the excreta of poultry, equines, and pigs
during his clinical work as a veterinarian, which is the possible
cause of the infection.
Amphotericin B is the choice of treatment for immunocompro-
mised patients with disseminated or limited disease. However,
treatment with itraconazole has also been reported as favorable.15
These data, combined with other reports,16 suggest that, with
localized lesions without detection of systemic signs or symptoms,
drugs with less toxicity, such as the itraconazole, should be chosen
for therapy.
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